Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Wilms tumor gene on the X chromosome (WTX) is a known tumor suppressor, but its role in colorectal cancer (CRC) is largely unknown.
• CRC is a leading cause of cancer death, necessitating research into its underlying mechanisms and potential therapeutic targets.

Purpose of the Study:

• To investigate the role of WTX in colorectal cancer (CRC) development and metastasis.
• To elucidate the molecular mechanisms by which WTX loss contributes to CRC progression.
• To identify potential therapeutic strategies targeting WTX regulation in CRC.

Main Methods:

• Analysis of WTX expression in CRC tissues and correlation with clinicopathological features.
• In vitro and in vivo experiments to study the functional impact of WTX loss on CRC cells.
• Investigation of the interaction between WTX, RhoGDIα, and CDC42 signaling pathways.
• Identification of microRNAs (miRNAs) regulating WTX expression in CRC.

Main Results:

• WTX is frequently lost in CRC, correlating significantly with increased cell proliferation, invasion, and metastasis.
• WTX loss disrupts the RhoGDIα-CDC42 interaction, activating CDC42 signaling and promoting CRC.
• Aberrant upregulation of miR-20a and miR-106a was identified as a key mechanism for WTX loss in CRC.
• These findings establish a novel molecular pathway regulating CRC progression and liver metastasis.

Conclusions:

• WTX functions as a tumor suppressor in CRC, and its loss promotes tumor progression and metastasis.
• The miR-20a/miR-106a-WTX axis represents a critical regulatory mechanism in CRC.
• Targeting this pathway may offer a novel therapeutic strategy for preventing CRC progression and metastasis.